Haemonetics Corp (HAE)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account
Sell

$62.72

Buy

$80.00

arrow-up$0.14 (+0.21%)

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
Prices updated at 30 May 2025, 21:44 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Devices
Chairman
Ms. Ellen M. Zane
CEO
Mr. Christopher A. Simon
Most recent earnings
31 Mar 2025
Fiscal year end
31 Mar 2025
Employees
3,023
Head office
125 Summer Street
Boston
United States
02110
mobile
+1 781 848-7100
letter
olga.guyette@haemonetics.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Charles J. Dockendorff
Independent Director
0.10m--0.30m-
Ms. Ellen M. Zane
Chairman of the Board
0.25m--0.45m-
Mr. Michael J. Coyle
Independent Director
0.08m--0.28m-
Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S.
Independent Director
0.08m--0.28m-
Mr. Robert E. Abernathy
Independent Director
0.10m--0.30m-
Ms. Diane M. Bryant
Independent Director
0.05m--0.25m-
Dr. Claire Pomeroy, M.B.A.,M.D.
Independent Director
0.09m--0.29m-
Mr. Christopher A. Simon
Director, President and Chief Executive Officer
1.09m--11.55m-
Mr. Lloyd E. Johnson
Independent Director
0.08m--0.28m-
Mr. Josep L. Llorens
Executive Vice President, Global Manufacturing and Supply Chain
0.49m--2.43m-
Mr. James C. D’Arecca
Executive Vice President and Chief Financial Officer
0.55m--3.15m-
Mr. Roy Galvin
Executive Vice President and Chief Commercial Officer
-----
Ms. Maryanne Maunsell Farris
Vice President and Chief Accounting Officer
-----
Mr. Frank W. Chan
Executive Vice President and Chief Operating Officer
-----
Mr. Stewart W. Strong
President, Global Hospital
-----
Ms. Michelle L. Basil
Executive Vice President and General Counsel
0.52m--3.07m-
Ms. Laurie A. Miller
Senior Vice President and Chief Human Resources Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc6,357,1640.008491972603.20232330 Apr 202513.29
Vanguard Group Inc5,099,6210.00586-79767-1.54008530 Apr 202510.66
Neuberger Berman Investment Advisers LLC4,348,3620.23146-70981-1.60614430 Apr 20259.09
Neuberger Berman Group LLC4,348,3620.23146-70981-1.60614430 Apr 20259.09
Wellington Management Group, LLP4,230,850-96276729.45968630 Apr 20258.42

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
01 Nov 2024-Mr. Roy Galvin71.4811,5087,373--
17 Sep 2024-Ms. Laurie A. Miller76.5418,21717,807--
29 Aug 2024-Mr. Christopher A. Simon75.563,000,034322,838--
26 Jul 2024-Mr. Stewart W. Strong91.15393,03918,196--
25 Jul 2024-Mr. Charles J. Dockendorff--4,433--
25 Jul 2024-Ms. Ellen M. Zane--16,680--
25 Jul 2024-Mr. Michael J. Coyle--12,701--
25 Jul 2024-Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S.--20,664--
25 Jul 2024-Mr. Robert E. Abernathy--22,288--
25 Jul 2024-Ms. Diane M. Bryant--4,433--
25 Jul 2024-Dr. Claire Pomeroy, M.B.A.,M.D.--14,179--
25 Jul 2024-Mr. Lloyd E. Johnson--10,240--
24 Jul 2024-Mr. Stewart W. Strong--25,306--
25 Jul 2024-Mr. Stewart W. Strong90.58253,44322,508--
12 Jul 2024-Ms. Anila Lingamneni90.007,11021,331--
11 Jul 2024-Ms. Anila Lingamneni90.00192,24021,410--
06 Jun 2024-Mr. Christopher A. Simon87.386,233,252362,542--
06 Jun 2024-Mr. Christopher A. Simon-----
06 Jun 2024-Mr. Christopher A. Simon41.644,352,046433,877--
28 May 2024-Mr. Stewart W. Strong95.73421,11627,053--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.